{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T04:09:11Z","timestamp":1790222951083,"version":"4.1.0"},"reference-count":38,"publisher":"MDPI AG","issue":"1","license":[{"start":{"date-parts":[[2023,12,24]],"date-time":"2023-12-24T00:00:00Z","timestamp":1703376000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Taysha Gene Therapies"},{"name":"Sinnett Laboratory"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Genes"],"abstract":"<jats:p>Inactivating mutations and the duplication of methyl-CpG binding protein 2 (MeCP2), respectively, mediate Rett syndrome (RTT) and MECP2 duplication syndrome. These disorders underscore the conceptual dose-dependent risk posed by MECP2 gene therapy for mosaic RTT patients. Recently, a miRNA-Responsive Autoregulatory Element (miRARE) mitigated the dose-dependent toxicity posed by self-complementary adeno-associated viral vector serotype 9 (AAV9) miniMECP2 gene therapy (scAAV9\/miniMECP2-myc) in mice. Here, we report an efficacy assessment for the human-ready version of this regulated gene therapy (TSHA-102) in male Mecp2\u2212\/y knockout (KO) mice after intracerebroventricular (ICV) administration at postnatal day 2 (P2) and after intrathecal (IT) administration at P7, P14 (\u00b1immunosuppression), and P28 (\u00b1immunosuppression). We also report qPCR studies on KO mice treated at P7-P35; protein analyses in KO mice treated at P38; and a survival safety study in female adult Mecp2\u2212\/+ mice. In KO mice, TSHA-102 improved respiration, weight, and survival across multiple doses and treatment ages. TSHA-102 significantly improved the front average stance and swing times relative to the front average stride time after P14 administration of the highest dose for that treatment age. Viral genomic DNA and miniMECP2 mRNA were present in the CNS. MiniMeCP2 protein expression was higher in the KO spinal cord compared to the brain. In female mice, TSHA-102 permitted survivals that were similar to those of vehicle-treated controls. In all, these pivotal data helped to support the regulatory approval to initiate a clinical trial for TSHA-102 in RTT patients (clinical trial identifier number NCT05606614).<\/jats:p>","DOI":"10.3390\/genes15010031","type":"journal-article","created":{"date-parts":[[2023,12,24]],"date-time":"2023-12-24T20:44:15Z","timestamp":1703450655000},"page":"31","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":33,"title":["The Efficacy of a Human-Ready miniMECP2 Gene Therapy in a Pre-Clinical Model of Rett Syndrome"],"prefix":"10.3390","volume":"15","author":[{"given":"Chanchal","family":"Sadhu","sequence":"first","affiliation":[{"name":"Formerly of Taysha Gene Therapies, Dallas, TX 75247, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher","family":"Lyons","sequence":"additional","affiliation":[{"name":"Formerly of the Department of Pediatrics, University of Texas Southwestern Medical Center (UTSWMC), Dallas, TX 75390, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiyoung","family":"Oh","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, University of Texas Southwestern Medical Center (UTSWMC), Dallas, TX 75390, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Indumathy","family":"Jagadeeswaran","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, University of Texas Southwestern Medical Center (UTSWMC), Dallas, TX 75390, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6240-8621","authenticated-orcid":false,"given":"Steven J.","family":"Gray","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, University of Texas Southwestern Medical Center (UTSWMC), Dallas, TX 75390, USA"},{"name":"Eugene McDermott Center for Human Growth and Development, University of Texas Southwestern Medical Center (UTSWMC), Dallas, TX 75390, USA"},{"name":"Peter O\u2019Donnell Jr. Brain Institute, University of Texas Southwestern Medical Center (UTSWMC), Dallas, TX 75390, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarah E.","family":"Sinnett","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, University of Texas Southwestern Medical Center (UTSWMC), Dallas, TX 75390, USA"},{"name":"Eugene McDermott Center for Human Growth and Development, University of Texas Southwestern Medical Center (UTSWMC), Dallas, TX 75390, USA"},{"name":"Peter O\u2019Donnell Jr. Brain Institute, University of Texas Southwestern Medical Center (UTSWMC), Dallas, TX 75390, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2023,12,24]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1007\/s00335-019-09793-5","article-title":"Treating Rett syndrome: From mouse models to human therapies","volume":"30","author":"Vashi","year":"2019","journal-title":"Mamm. Genome"},{"key":"ref_2","doi-asserted-by":"crossref","unstructured":"Pascual-Alonso, A., Martinez-Monseny, A.F., Xiol, C., and Armstrong, J. (2021). MECP2-Related Disorders in Males. Int. J. Mol. Sci., 22.","DOI":"10.3390\/ijms22179610"},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1038\/13810","article-title":"Rett syndrome is caused by mutations in X-linked MECP2, encoding methyl-CpG-binding protein 2","volume":"23","author":"Amir","year":"1999","journal-title":"Nat. Genet."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1016\/S1474-4422(20)30217-9","article-title":"Advances in understanding of Rett syndrome and MECP2 duplication syndrome: Prospects for future therapies","volume":"19","author":"Sandweiss","year":"2020","journal-title":"Lancet Neurol."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1016\/j.pediatrneurol.2015.06.003","article-title":"The Changing Face of Survival in Rett Syndrome and MECP2-Related Disorders","volume":"53","author":"Tarquinio","year":"2015","journal-title":"Pediatr. Neurol."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1038\/mt.2012.200","article-title":"Improved survival and reduced phenotypic severity following AAV9\/MECP2 gene transfer to neonatal and juvenile male Mecp2 knockout mice","volume":"21","author":"Gadalla","year":"2013","journal-title":"Mol. Ther."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1016\/j.omtm.2017.04.007","article-title":"Development of a Novel AAV Gene Therapy Cassette with Improved Safety Features and Efficacy in a Mouse Model of Rett Syndrome","volume":"5","author":"Gadalla","year":"2017","journal-title":"Mol. Ther. Methods Clin. Dev."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"3005","DOI":"10.1093\/brain\/awab182","article-title":"Engineered microRNA-based regulatory element permits safe high-dose miniMECP2 gene therapy in Rett mice","volume":"144","author":"Sinnett","year":"2021","journal-title":"Brain"},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1016\/j.omtm.2017.04.006","article-title":"Improved MECP2 Gene Therapy Extends the Survival of MeCP2-Null Mice without Apparent Toxicity after Intracisternal Delivery","volume":"5","author":"Sinnett","year":"2017","journal-title":"Mol. Ther. Methods Clin. Dev."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.nbd.2016.12.009","article-title":"A codon-optimized Mecp2 transgene corrects breathing deficits and improves survival in a mouse model of Rett syndrome","volume":"99","author":"Matagne","year":"2017","journal-title":"Neurobiol. Dis."},{"key":"ref_11","doi-asserted-by":"crossref","unstructured":"Matagne, V., Borloz, E., Ehinger, Y., Saidi, L., Villard, L., and Roux, J.C. (2021). Severe offtarget effects following intravenous delivery of AAV9-MECP2 in a female mouse model of Rett syndrome. Neurobiol. Dis., 149.","DOI":"10.1016\/j.nbd.2020.105235"},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1038\/nature24058","article-title":"Radically truncated MeCP2 rescues Rett syndrome-like neurological defects","volume":"550","author":"Tillotson","year":"2017","journal-title":"Nature"},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"e52629","DOI":"10.7554\/eLife.52629","article-title":"Whole brain delivery of an instability-prone Mecp2 transgene improves behavioral and molecular pathological defects in mouse models of Rett syndrome","volume":"9","author":"Luoni","year":"2020","journal-title":"Elife"},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"13612","DOI":"10.1523\/JNEUROSCI.1854-13.2013","article-title":"Systemic delivery of MeCP2 rescues behavioral and cellular deficits in female mouse models of Rett syndrome","volume":"33","author":"Garg","year":"2013","journal-title":"J. Neurosci."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"2767","DOI":"10.1016\/j.ymthe.2023.07.013","article-title":"Novel MECP2 gene therapy is effective in a multicenter study using two mouse models of Rett syndrome and is safe in non-human primates","volume":"31","author":"Powers","year":"2023","journal-title":"Mol. Ther."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1007\/s12264-022-00974-y","article-title":"Extension of the Lifespan of a Mouse Model of Rett Syndrome by Intracerebroventricular Delivery of MECP2","volume":"39","author":"Yang","year":"2023","journal-title":"Neurosci. Bull"},{"key":"ref_17","first-page":"153","article-title":"Recent endeavors in MECP2 gene transfer for gene therapy of Rett syndrome","volume":"24","author":"Sinnett","year":"2017","journal-title":"Discov. Med."},{"key":"ref_18","unstructured":"Taysha Gene Therapies (2023, November 03). Safety and Efficacy of TSHA-102 in Adult Females With Rett Syndrome (REVEAL Adult Study), Available online: https:\/\/clinicaltrials.gov\/study\/NCT05606614?term=Safety%20and%20Efficacy%20of%20TSHA-102%20in%20Adult%20Females%20With%20Rett%20Syndrome%20(REVEAL%20Adult%20Study)&rank=1."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/j.anpedi.2009.02.007","article-title":"Nutrition and gastrointestinal disorders in Rett syndrome: Importance of early intervention","volume":"72","author":"Prior","year":"2010","journal-title":"An. Pediatr."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"1512","DOI":"10.1002\/aur.2508","article-title":"Dietary intake and growth deficits in Rett syndrome-A cross-section study","volume":"14","author":"Wong","year":"2021","journal-title":"Autism. Res."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1097\/MPG.0b013e31829e0b65","article-title":"Assessment and management of nutrition and growth in Rett syndrome","volume":"57","author":"Leonard","year":"2013","journal-title":"J. Pediatr. Gastroenterol. Nutr."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"1143","DOI":"10.1126\/science.1138389","article-title":"Reversal of neurological defects in a mouse model of Rett syndrome","volume":"315","author":"Guy","year":"2007","journal-title":"Science"},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/B978-0-323-91532-8.00018-5","article-title":"Breathing disturbances in Rett syndrome","volume":"189","author":"Ramirez","year":"2022","journal-title":"Handb. Clin. Neurol."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"e64833","DOI":"10.7554\/eLife.64833","article-title":"Deleting Mecp2 from the cerebellum rather than its neuronal subtypes causes a delay in motor learning in mice","volume":"10","author":"Achilly","year":"2021","journal-title":"Elife"},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"1602","DOI":"10.1016\/j.jmb.2019.10.004","article-title":"The Molecular Basis of MeCP2 Function in the Brain","volume":"432","author":"Tillotson","year":"2020","journal-title":"J. Mol. Biol."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1038\/pr.2015.109","article-title":"Augmentation of transgene-encoded protein after neonatal injection of adeno-associated virus improves hepatic copy number without immune responses","volume":"78","author":"Tai","year":"2015","journal-title":"Pediatr. Res."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"2224","DOI":"10.1128\/JVI.72.3.2224-2232.1998","article-title":"Production of high-titer recombinant adeno-associated virus vectors in the absence of helper adenovirus","volume":"72","author":"Xiao","year":"1998","journal-title":"J. Virol."},{"key":"ref_28","unstructured":"Sundberg, J.P., Cunlifee-Beamer, T., Brown, K.S., and Bronson, R. (2023, November 03). Spontaneous Hydrocephalus in Inbred Strains of Mice. JAX Notes 1991. Available online: https:\/\/www.jax.org\/news-and-insights\/1991\/april\/spontaneous-hydrocephalus-in-inbred-strains-of-mice#:~:text=Hydrocephalus%20is%20a%20disease%20that,has%20been%20recorded%20or%20published."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1038\/85899","article-title":"A mouse Mecp2-null mutation causes neurological symptoms that mimic Rett syndrome","volume":"27","author":"Guy","year":"2001","journal-title":"Nat. Genet."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1177\/1091581817741840","article-title":"Toxicology Evaluation of Drugs Administered via Uncommon Routes: Intranasal, Intraocular, Intrathecal\/Intraspinal, and Intra-Articular","volume":"37","author":"Emami","year":"2018","journal-title":"Int. J. Toxicol."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.pneurobio.2013.04.001","article-title":"Brain development in rodents and humans: Identifying benchmarks of maturation and vulnerability to injury across species","volume":"106\u2013107","author":"Semple","year":"2013","journal-title":"Prog. Neurobiol."},{"key":"ref_32","unstructured":"Motulsky, H.J. (2023, November 03). Censored Data. GraphPad Statistics Guide. Available online: https:\/\/www.graphpad.com\/guides\/prism\/latest\/statistics\/stat_censored_data.htm."},{"key":"ref_33","unstructured":"Motulsky, H.J. (2023, November 03). Q & A: Entering Survival Data. GraphPad Statistics Guide. Available online: https:\/\/www.graphpad.com\/guides\/prism\/latest\/statistics\/common_questions_about_entering_survival_data.htm."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1242\/dmm.011007","article-title":"Preclinical research in Rett syndrome: Setting the foundation for translational success","volume":"5","author":"Katz","year":"2012","journal-title":"Dis. Model. Mech."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"2626","DOI":"10.1093\/hmg\/ddt111","article-title":"Insulinotropic treatments exacerbate metabolic syndrome in mice lacking MeCP2 function","volume":"22","author":"Pitcher","year":"2013","journal-title":"Hum. Mol. Genet."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"e05005","DOI":"10.7554\/eLife.05005","article-title":"Predicting effective microRNA target sites in mammalian mRNAs","volume":"4","author":"Agarwal","year":"2015","journal-title":"Elife"},{"key":"ref_37","unstructured":"Gray, S.J., and Sinnett, S.E. (2023, November 03). WO2020047234\u2014Feedback Enabled Synthetic Genes, Target Seed Match Cassettes, and Their Uses. WIPO 2020. Available online: https:\/\/patentscope.wipo.int\/search\/en\/detail.jsf?docId=WO2020047234."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"848","DOI":"10.1038\/mp.2013.93","article-title":"Identification of differentially expressed microRNAs across the developing human brain","volume":"19","author":"Ziats","year":"2014","journal-title":"Mol. Psychiatry"}],"container-title":["Genes"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2073-4425\/15\/1\/31\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T21:41:24Z","timestamp":1760132484000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2073-4425\/15\/1\/31"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,12,24]]},"references-count":38,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,1]]}},"alternative-id":["genes15010031"],"URL":"https:\/\/doi.org\/10.3390\/genes15010031","relation":{},"ISSN":["2073-4425"],"issn-type":[{"value":"2073-4425","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,12,24]]}}}